DSGN
Design Therapeutics Inc.
Company Overview
| Mkt Cap | $344.54M | Price | $6.70 |
| Volume | 65.08K | Change | +2.60% |
| P/E Ratio | -6.9 | Open | $6.48 |
| Revenue | -- | Prev Close | $6.53 |
| Net Income | $-49.6M | 52W Range | $2.60 - $7.77 |
| Div Yield | N/A | Target | $7.33 |
| Overall | 55 | Value | 60 |
| Quality | 42 | Technical | 63 |
No chart data available
Stock Overview
Updated DailyDesign Therapeutics Inc. (DSGN) is a leading Professional, Scientific, and Technical Services company in the Research and Development in Biotechnology industry, currently trading at $6.70 with a market capitalization of $344.54 million. The stock is positioned in the upper portion of its trading range, demonstrating below-average quality metrics with a MarketXLS quality score of 42.
Today's trading session shows DSGN with a volume of 65K shares. The stock opened down 0.77% from yesterday's close of $6.53. Current analyst estimates project earnings of $-1.33 per share for this year, with next year targeting $-1.42.
DSGN demonstrates positive technical signals based on technical analysis. The company trades on the NGS exchange and operates alongside industry peers including OTIC, OTLC, OVAT-CA, ORTH-CA.
Key investment considerations for DSGN include average overall investment profile. The company offers a dividend yield of NA% and analyst price targets suggest potential upside of 9.4%. The stock shows fair valuation metrics based on valuation analysis.
Analysis generated on November 3, 2025 at 11:16 AM
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | DSGN | $6.70 | +2.6% | 65.08K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Design Therapeutics Inc. Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW